Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
IN-VITRO ACTIVITY OF QUINUPRISTIN DALFOPRISTIN, RP59500, AGAINST GRAM-POSITIVE CLINICAL ISOLATES/
Autore:
QADRI SMH; UENO Y; ABUMOSTAFA FM; HALIM M;
Indirizzi:
KING FAISAL SPECIALIST HOSP & RES CTR,MBC-10,POB 3354 RIYADH 11211 SAUDI ARABIA
Titolo Testata:
Chemotherapy
fascicolo: 2, volume: 43, anno: 1997,
pagine: 94 - 99
SICI:
0009-3157(1997)43:2<94:IAOQDR>2.0.ZU;2-F
Fonte:
ISI
Lingua:
ENG
Soggetto:
RESISTANT ENTEROCOCCUS-FAECIUM; VANCOMYCIN-RESISTANT; INFECTIONS; MORTALITY; BACTEREMIA; STAY;
Keywords:
QUINUPRISTIN/DALFOPRISTIN; SYNERCID; IN VITRO ACTIVITY; RP59500; STREPTOGRAMIN;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
27
Recensione:
Indirizzi per estratti:
Citazione:
S.M.H. Qadri et al., "IN-VITRO ACTIVITY OF QUINUPRISTIN DALFOPRISTIN, RP59500, AGAINST GRAM-POSITIVE CLINICAL ISOLATES/", Chemotherapy, 43(2), 1997, pp. 94-99

Abstract

Synercid(TM) (quinupristin/dalfopristin, RP59500) is a new water-soluble streptogramin which offers some advantages over the commercially available antimicrobials against drug-resistant gram-positive bacteria. Its in vitro activity was compared with ampicillin, augmentin, penicillin, erythromycin, oxacillin and vancomycin against gram-positive bacteria isolated from clinical specimens. Of the 837 gram-positive bacteria tested 834 (99.6%) were inhibited by <0.6-4.0 mg/l of Synercid. Ithad excellent activity against both staphylococci and streptococci, including methicillin-resistant staphylococci and vancomycin-resistant enterococci.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/09/20 alle ore 23:30:39